The Public Health Challenge of Δ8-THC and Derived Psychoactive Cannabis Products

JAMA. 2024 Mar 12;331(10):834-836. doi: 10.1001/jama.2024.0801.

Authors

Jennifer M Whitehill¹, Kelly E Dunn², Renee M Johnson³

Affiliations

¹ Department of Health Promotion and Policy, School of Public Health and Health Sciences, University of Massachusetts Amherst, Amherst.
² Department of Psychiatry and Behavioral Sciences, School of Medicine, Johns Hopkins University, Baltimore, Maryland.
³ Department of Mental Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland.

PMID: 38470394
DOI: 10.1001/jama.2024.0801

No abstract available

Publication types

Editorial

MeSH terms

Cannabis*
Dronabinol* / analogs & derivatives
Marijuana Use* / epidemiology
Psychotropic Drugs*
Public Health*
United States / epidemiology

Substances

delta-8-tetrahydrocannabinol
Dronabinol
Psychotropic Drugs